Hudson Bay Capital Management’s Cytokinetics CYTK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.6M	Sell	39,470 -135,880	-77%	-$8.64M	0.02%	694
2025 Q4	$11.1M	Sell	175,350 -6,781	-4%	-$422K	0.06%	324
2025 Q3	$10M	Buy	182,131 +24,345	+15%	+$1M	0.06%	355
2025 Q2	$5.21M	Buy	157,786 +10,523	+7%	+$366K	0.03%	540
2025 Q1	$5.92M	Buy	147,263 +5,994	+4%	+$275K	0.04%	550
2024 Q4	$6.65M	Buy	141,269 +73,769	+109%	+$3.83M	0.04%	445
2024 Q3	$3.56M	Buy	67,500 +37,500	+125%	+$2.09M	0.02%	486
2024 Q2	$1.63M	Sell	30,000 -217,566	-88%	-$13.1M	0.01%	547
2024 Q1	$17.4M	Buy	+247,566	New	+$19.1M	0.15%	114
2023 Q4	–	Sell	-80,000	Closed	-$2.36M	–	779
2023 Q3	$2.36M	Buy	80,000 +60,000	+300%	+$2M	0.02%	451
2023 Q2	$652K	Buy	+20,000	New	+$740K	0.01%	620
2020 Q3	–	Sell	-50,000	Closed	-$1.18M	–	574
2020 Q2	$1.18M	Sell	50,000 -125,000	-71%	-$2.34M	0.02%	365
2020 Q1	$2.06M	Sell	175,000 -50,000	-22%	-$638K	0.05%	260
2019 Q4	$2.39M	Buy	+225,000	New	+$2.31M	0.06%	259